Regenecare® Wound Gel in Treating Rash in Patients Receiving Cetuximab or Other Epidermal Growth Factor Receptor Inhibitor Therapy for Cancer

NCT00498992 · clinicaltrials.gov ↗

NA

Phase

UNKNOWN

Status

20

Enrollment

OTHER

Sponsor class

Conditions

Dermatologic Complications
Unspecified Adult Solid Tumor, Protocol Specific

Interventions

DIETARY_SUPPLEMENT: collagen/aloe vera/vitamin E/lidocaine topical hydrogel

Sponsor

Ingalls Memorial Hospital